1-100011413-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000533028.8(SLC35A3):c.514C>T(p.Gln172Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000421 in 1,423,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q172Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000533028.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC35A3 | NM_012243.3 | c.514C>T | p.Gln172Ter | stop_gained | 5/8 | ENST00000533028.8 | NP_036375.1 | |
LOC124904230 | XR_007066249.1 | n.279+26317G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35A3 | ENST00000533028.8 | c.514C>T | p.Gln172Ter | stop_gained | 5/8 | 1 | NM_012243.3 | ENSP00000433849 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000421 AC: 6AN: 1423568Hom.: 0 Cov.: 25 AF XY: 0.00000424 AC XY: 3AN XY: 708130
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autism spectrum disorder - epilepsy - arthrogryposis syndrome Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2022 | ClinVar contains an entry for this variant (Variation ID: 89029). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with SLC35A3-related conditions (PMID: 24031089). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln172*) in the SLC35A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC35A3 are known to be pathogenic (PMID: 24031089, 28328131). - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 28, 2022 | Variant summary: SLC35A3 c.514C>T (p.Gln172X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 239390 control chromosomes. c.514C>T has been reported in the literature in multiple individuals from a large kindred affected with autism spectrum disorder, epilepsy and arthrogryposis (Edvardson_2013). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at